Cancer Melanoma or Skin Cancer

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Melanoma or Skin Cancer Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Melanoma or Skin Cancer Projects
--Bayer Ag
--AstraZeneca Plc
--Bristol-Myers Squibb Company
--BioNumerik Pharmaceuticals, Inc.
--Curacyte AG
--Celgene Corporation
--GlaxoSmithKline plc
--Eli Lilly & Co
--Medarex Inc
--Immutep S.A.
--Oxford BioMedica plc
--Onyx Pharmaceuticals Inc
--PharmaMar
--Pfizer Inc
--Progen Pharmaceuticals Ltd.
--PhotoCure ASA
--Sigma-Tau S.p.A.
--Schering-Plough Corp
--ViroTarg Pty Ltd
--Topotarget A/S

--Top Companies in early stage Melanoma or Skin Cancer Projects
--Aphios Corporation
--Amgen Inc
--BioLife Science, Inc
--Argos Therapeutics, Inc.,
--erly Merix Bioscience)
--Eisai Co Ltd
--Bolder BioTechnology, Inc.
--GlobeImmune, Inc.
--Genta Incorporated
--Imclone Systems Inc
--HanAll Pharmaceutical
--Marshall Edwards Inc
--Inovio Biomedical Corp
--Nautilus Biotech
--Medical Therapies Ltd
--Novogen Ltd
--Novartis AG
--Protiva Biotherapeutics Inc
--Plexxikon Inc
--Targa Therapeutics Corp.
--Roche Holdings Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View